Benvenue Medical raised $25 million in a Series D round of financing, planning to use the funds to penetrate the $9 billion global spine device market with support for commercialization in the U.S. and abroad.
The privately held spinal devices maker, launched in 2004, said it’s "well-poised for rapid U.S. and global sales" of its trio of minimally invasive surgical and interventional products for treatment of degenerative disc disease and vertebral compression fractures.